Swiss pharmaceutical company Roivant Sciences has created a subsidiary , catalyst , to focus on sourcing personalised medications by connecting de - identified patient data with physician data via a technology platform . it has been working on the integration of drug development and commercialisation using AI and data science tools through its subsidiaries , catalyst Datavant .
Swiss pharmaceutical company Roivant Sciences has created a subsidiary, Alyvant, to focus on sourcing personalised medications by connecting de-identified patient data with physician data via a technology platform. Roivant has been working on the acceleration of drug development and commercialisation using AI and data science technology through its subsidiaries, including Datavant.